Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP235274.RAzuBvLN4cOZ5hHbzy9KmXm89L1wcaC_-kS-fytsbOTdg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP235274.RAzuBvLN4cOZ5hHbzy9KmXm89L1wcaC_-kS-fytsbOTdg130_assertion type Assertion NP235274.RAzuBvLN4cOZ5hHbzy9KmXm89L1wcaC_-kS-fytsbOTdg130_head.
- NP235274.RAzuBvLN4cOZ5hHbzy9KmXm89L1wcaC_-kS-fytsbOTdg130_assertion description "[K-ras point mutations were observed in 1/2 of the atypical hyperplasia (codon 12: GGT-->GTT) and 3/9 of the carcinoma (codon 12: GGT-->GAT, GGT-->AGT, codon 61: CAA-->CAC), while they were not detected in 7 of the normal tissues and in 5 of the simple or complex hyperplasia without atypia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235274.RAzuBvLN4cOZ5hHbzy9KmXm89L1wcaC_-kS-fytsbOTdg130_provenance.
- NP235274.RAzuBvLN4cOZ5hHbzy9KmXm89L1wcaC_-kS-fytsbOTdg130_assertion evidence source_evidence_literature NP235274.RAzuBvLN4cOZ5hHbzy9KmXm89L1wcaC_-kS-fytsbOTdg130_provenance.
- NP235274.RAzuBvLN4cOZ5hHbzy9KmXm89L1wcaC_-kS-fytsbOTdg130_assertion SIO_000772 10775052 NP235274.RAzuBvLN4cOZ5hHbzy9KmXm89L1wcaC_-kS-fytsbOTdg130_provenance.
- NP235274.RAzuBvLN4cOZ5hHbzy9KmXm89L1wcaC_-kS-fytsbOTdg130_assertion wasDerivedFrom befree-20140225 NP235274.RAzuBvLN4cOZ5hHbzy9KmXm89L1wcaC_-kS-fytsbOTdg130_provenance.
- NP235274.RAzuBvLN4cOZ5hHbzy9KmXm89L1wcaC_-kS-fytsbOTdg130_assertion wasGeneratedBy ECO_0000203 NP235274.RAzuBvLN4cOZ5hHbzy9KmXm89L1wcaC_-kS-fytsbOTdg130_provenance.